Hydroquinone for Pigmentation and Melasma: How to Use It Safely
Part of: Melasma & pigmentation
When hydroquinone helps pigmentation and melasma, how 2% and 4% differ, how long treatment lasts, the risks of prolonged use, and when to stop.
Pigmentation & melasma · 4 min read · October 7, 2026
Written and medically reviewed by Dr. Yousef Abo Zarad · German board-certified dermatologist · Last reviewed: October 2026
The short answer
Hydroquinone is one of the strongest topical treatments used for melasma.4 It is also used for dark pigmentation left after inflammation or acne.1 It is not a general face-lightening cream to use for months or years without review.
Unstructured use can irritate the skin.6 With very prolonged use, especially at higher strengths, a rare complication can make pigmentation turn blue-grey instead of lighter.5
Which types of pigmentation can it help?
It is most useful when excess melanin is part of the problem, including:
- Melasma.
- Dark marks left after acne or other inflammation.1
- Some other acquired pigment problems once the diagnosis is clear.
Hydroquinone is not a treatment for every brown spot. A mole, a changing or bleeding lesion, or a new unusual spot should be diagnosed before any lightening cream is applied. Under-eye darkness caused by vessels, hollowing or shadowing will not be fixed by hydroquinone.
2% or 4%?
Hydroquinone comes in different strengths, but 4% is among the best-studied concentrations for melasma.4
That does not make 4% the right starting point for everyone. Very sensitive skin or milder pigmentation may call for a different strength or a different treatment.
For melasma, there is also a triple-combination cream containing hydroquinone 4% and tretinoin 0.05%.6
Fluocinolone 0.01% is the third ingredient, and this combination remains one of the strongest medical treatments for melasma when used under supervision.4
When do results start?
Do not expect a meaningful change in a few days.
In a 2024 trial of hydroquinone 4%, melasma severity fell by about 45% after 60 days.3
That is why treatment is usually judged after several weeks rather than after one week. If pigmentation has not improved after a reasonable course, the diagnosis and plan should be reviewed before simply continuing for more months.
How long should it be used?
Hydroquinone is not meant to stay in a routine indefinitely.
It is usually used for a defined treatment period and then reviewed. The triple combination containing hydroquinone 4% is labelled for short-term melasma treatment, not continuous maintenance.6
There is no single day when hydroquinone suddenly becomes unsafe. The concern is prolonged, unsupervised use over many months or years.
What is ochronosis?
Exogenous ochronosis is an abnormal pigment change in which the skin becomes blue-grey or blue-black instead of lighter.
It is a rare but recognized complication of hydroquinone.5
In a review of published cases, use was usually very prolonged: the median duration was about 5 years, and cases were more often reported with concentrations above 4%.5
The main concern is not a short, supervised course. It is prolonged, unstructured use. If the treated area starts turning grey or blue, hydroquinone should be stopped and the skin examined.
Should it be used over the whole face?
It should not be used as a general bleaching cream.
It is applied to the area that actually needs treatment. Melasma can cover a broader area, while post-acne marks may need a more targeted approach.
Applying it to inflamed or broken skin does not speed treatment. Irritation itself can worsen pigmentation, especially in darker skin tones.
Can it be used with tretinoin?
Yes. Hydroquinone and tretinoin have long been used together in melasma treatment.
The established triple combination contains hydroquinone 4% and tretinoin 0.05%.6
Fluocinolone 0.01% is added as the third ingredient, and the combination is used short term for moderate-to-severe melasma.6
Stacking several strong actives at random is not recommended, because persistent irritation can make pigmentation worse rather than better.
Can it be used during pregnancy?
Hydroquinone is best avoided during pregnancy.
The issue is not strong evidence that it causes birth defects. Safety data are limited, and skin absorption is relatively high. In an older absorption study, about 45% of an applied 2% cream dose became systemically available.7
When the condition is cosmetic and treatment can wait, avoiding hydroquinone during pregnancy is recommended.8
Sunscreen is part of the treatment
Treating melasma or pigmentation while getting daily unprotected sun exposure works against the treatment.
For melasma, daily photoprotection is part of the plan. A tinted sunscreen containing iron oxides can also help protect against visible light.2
When should you stop?
Hydroquinone should be stopped and the plan reviewed when the skin develops an unusual reaction or continued use no longer makes sense.
- Severe redness or burning that does not settle after cutting back.
- A blue-grey or blue-black change in the treated area.
- A clear allergic reaction or swelling.
- A spot that starts changing in an unusual way.
- No meaningful improvement after an appropriate treatment period.
Using hydroquinone for years simply because you are worried pigmentation will return is not recommended. Melasma can relapse because the condition itself tends to recur. The answer is a maintenance and protection plan, not indefinite hydroquinone.6
Medical Evidence
- Global consensus on the management of melanin hyperpigmentation disorders (Passeron et al., 2026)
- Melasma: Diagnosis and treatment
- Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial (de Amorim et al., 2024)
- Topical and Systemic Therapies in Melasma: A Systematic Review
- Exogenous ochronosis associated with hydroquinone: a systematic review (Ishack & Lipner, 2022)
- TRI-LUMA (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) — official drug label
- Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition (Wester et al., 1998)
- Safety of skin care products during pregnancy (Bozzo et al., 2011)